State-of-the-art technology for cancer therapy.

We are scaling up the production of radionuclides for cancer therapy (radioligand therapy). To do this, we use particle accelerators, thus using electricity instead of research or nuclear reactors, and recycle our starting material.

Our accelerators are in a safe radiation protection environment and pose no safety risk. Our processes allow GMP products with very high levels of purity and thus protect patients.

LinaThera makes radionuclides for radioligand therapy accessible on a large scale – for research, development and, above all, for reliable patient care.